Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Katayama

Showing results (461-470 of 491) with videos related to

Pageof 50
Sort By:
Cancer Treatment Reviews|January 2, 2022
Clinical development of IDH1 inhibitors for cancer therapyMehrdad Zarei, Jonathan J Hue, Omid Hajihassani, et al.
Surgical Oncology|November 4, 2024
Cost effectiveness of immune checkpoint inhibitors for treatment of Hepatocellular Carcinoma: A systematic review and Meta-analysisZaiba Shafik Dawood, Zachary J Brown, Yutaka Endo, et al.
Journal of Pharmaceutical Sciences|September 7, 2004
Retrospective statistical analysis of lyophilized protein formulations of progenipoietin using PLS: determination of the critical parameters for long-term storage stabilityDerrick S Katayama, Carol F Kirchhoff, Carrie M Elliott, et al.
Journal of Pharmaceutical Sciences|April 26, 2006
Effect of buffer species on the thermally induced aggregation of interferon-tauDerrick S Katayama, Rajiv Nayar, Danny K Chou, et al.
Infection|June 12, 2024
Low expression of the CCL5 gene and low serum concentrations of CCL5 in severe invasive group a streptococcal diseaseV Kailankangas, S Katayama, K Gröndahl-Yli-Hannuksela, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 18, 2024
Comparison of tumor response and outcomes of patients with hepatocellular carcinoma after multimodal treatment including immune checkpoint inhibitors - a systematic review and meta-analysisZaiba S Dawood, Zachary J Brown, Laura Alaimo, et al.
Diabetologia|October 31, 2009
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) studyE Ritz, G C Viberti, L M Ruilope, et al.
JSES International|February 25, 2026
Recurrence rates and outcomes of shoulder stabilization surgery in patients with seizuresLouis W Barry, Benjamin Brej, Erryk S Katayama, et al.
Surgery|April 6, 2024
Inflammatory bowel disease-associated colorectal cancer negatively affects surgery outcomes and health care costsErryk S Katayama, Selamawit Woldesenbet, Diamantis Tsilimigras, et al.
Research Communications in Molecular Pathology and Pharmacology|April 2, 1998
Clinical significance of serum P53 antibody in patients with gastric cancerG Shiota, M Ishida, N Noguchi, et al.
Pageof 50

Showing results (461-470 of 491) with videos related to

Sort By:
Pageof 50
Cancer Treatment Reviews|January 2, 2022
Clinical development of IDH1 inhibitors for cancer therapyMehrdad Zarei, Jonathan J Hue, Omid Hajihassani, et al.
Surgical Oncology|November 4, 2024
Cost effectiveness of immune checkpoint inhibitors for treatment of Hepatocellular Carcinoma: A systematic review and Meta-analysisZaiba Shafik Dawood, Zachary J Brown, Yutaka Endo, et al.
Journal of Pharmaceutical Sciences|September 7, 2004
Retrospective statistical analysis of lyophilized protein formulations of progenipoietin using PLS: determination of the critical parameters for long-term storage stabilityDerrick S Katayama, Carol F Kirchhoff, Carrie M Elliott, et al.
Journal of Pharmaceutical Sciences|April 26, 2006
Effect of buffer species on the thermally induced aggregation of interferon-tauDerrick S Katayama, Rajiv Nayar, Danny K Chou, et al.
Infection|June 12, 2024
Low expression of the CCL5 gene and low serum concentrations of CCL5 in severe invasive group a streptococcal diseaseV Kailankangas, S Katayama, K Gröndahl-Yli-Hannuksela, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 18, 2024
Comparison of tumor response and outcomes of patients with hepatocellular carcinoma after multimodal treatment including immune checkpoint inhibitors - a systematic review and meta-analysisZaiba S Dawood, Zachary J Brown, Laura Alaimo, et al.
Diabetologia|October 31, 2009
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) studyE Ritz, G C Viberti, L M Ruilope, et al.
JSES International|February 25, 2026
Recurrence rates and outcomes of shoulder stabilization surgery in patients with seizuresLouis W Barry, Benjamin Brej, Erryk S Katayama, et al.
Surgery|April 6, 2024
Inflammatory bowel disease-associated colorectal cancer negatively affects surgery outcomes and health care costsErryk S Katayama, Selamawit Woldesenbet, Diamantis Tsilimigras, et al.
Research Communications in Molecular Pathology and Pharmacology|April 2, 1998
Clinical significance of serum P53 antibody in patients with gastric cancerG Shiota, M Ishida, N Noguchi, et al.
Pageof 50